ExThera Medical
Martinez, US · Delaware corporation · 2 known investors
BiotechHealthtech
Founders & leadership
MD
Michael DiMeoExecutive Officer
EB
Erin BorgerExecutive Officer, Director
RS
Robert S. WardExecutive Officer, Director
KM
Keith McCreaExecutive Officer, Director
EJ
Eber JaquesDirector
GP
George PitarraExecutive Officer, Director
KW
Kathleen WhiteExecutive Officer
JF
John FeikDirector
JP
John PrestonDirector
JP
Jacqueline PriceDirector
LC
Lakhmir ChawlaDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$1.5MraisedSep 2024 · 23 investors · Other Health CareRule 506(b)
▶$1.5MraisedSep 2024 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael DiMeoExecutive Officer
- Erin BorgerExecutive Officer, Director
- Jacqueline PriceDirector
- John PrestonDirector
- Robert S. WardExecutive Officer, Director
- Lakhmir ChawlaDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedSep 2021 · 12 investors · Other Health CareRule 506(b)
▶$6.7MraisedSep 2021 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert S. WardExecutive Officer, Director
- Lakhmir ChawlaDirector
- Michael BenjaminExecutive Officer
- Greg DollarhydeDirector
- Erin BorgerDirector
- John PrestonDirector
- Offering amount
- $20M
- Amount sold
- $6.7M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.6MraisedMar 2021 · 66 investors · Other Health CareRule 506(b)
▶$20.6MraisedMar 2021 · 66 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert S. WardExecutive Officer, Director
- John PrestonDirector
- Lakhmir ChawlaExecutive Officer, Director
- Michael PorterDirector
- Greg DollarhydeDirector
- Offering amount
- $20.6M
- Amount sold
- $20.6M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedMay 2016 · 29 investors · BiotechnologyRule 506(b)
▶$6.7MraisedMay 2016 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathleen WhiteExecutive Officer
- John FeikDirector
- George PitarraExecutive Officer, Director
- Eber JaquesDirector
- Robert WardExecutive Officer, Director
- Keith McCreaExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $6.7M
- Minimum investment
- $20K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.3MraisedMay 2016 · 30 investors · BiotechnologyRule 506(b)
▶$15.3MraisedMay 2016 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keith McCreaExecutive Officer, Director
- Eber JaquesDirector
- George PitarraExecutive Officer, Director
- Robert WardExecutive Officer, Director
- Kathleen WhiteExecutive Officer
- John FeikDirector
- Offering amount
- $15.4M
- Amount sold
- $15.3M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedMay 2016 · 20 investors · BiotechnologyRule 506(b)
▶$12MraisedMay 2016 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keith McCreaExecutive Officer, Director
- Kathleen WhiteExecutive Officer
- George PitarraExecutive Officer, Director
- Robert WardExecutive Officer, Director
- John FeikDirector
- Eber JaquesDirector
- Offering amount
- $12.5M
- Amount sold
- $12M
- First sale
- Apr 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.